PBSCT is associated with poorer survival and increased chronic GvHD than BMT in Japanese paediatric patients with acute leukaemia and an HLA-matched sibling donor

Pediatric Blood and Cancer

Volumn 60, Issue 9, 2013, Pages 1513-1519

  Shinzato, Aki ^a   Tabuchi, Ken ^b   Atsuta, Yoshiko ^c   Inoue, Masami ^d   Inagaki, Jiro ^e   Yabe, Hiromasa ^f   Koh, Katsuyoshi ^g   Kato, Koji ^h   Ohta, Hideaki ⁱ   Kigasawa, Hisato ^b   Kitoh, Toshiyuki ^j   Ogawa, Atsushi ^k   Takahashi, Yoshiyuki ^l   Sasahara, Yoji ^m   Kato, Shun Ichi ^f   Adachi, Souichi ^a  

^a KYOTO UNIVERSITY   (Japan)

^b KANAGAWA CHILDREN'S MEDICAL CENTER   (Japan)

^c NAGOYA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^d RESEARCH INSTITUTE FOR MATERNAL AND CHILD HEALTH   (Japan)

^e NATIONAL KYUSHU CANCER CENTER   (Japan)

^f TOKAI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^g SAITAMA CHILDREN'S MEDICAL CENTER   (Japan)

^h JAPANESE RED CROSS NAGOYA FIRST HOSPITAL   (Japan)

ⁱ OSAKA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^j SHIGA MEDICAL CENTER FOR CHILDREN   (Japan)

^k NIIGATA CANCER CENTER HOSPITAL   (Japan)

^l NAGOYA UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^m TOHOKU UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

more..

Author keywords

Acute leukaemia; Bone marrow transplantation; Children; Chronic graft versus host disease; Peripheral blood stem cell transplantation

Indexed keywords

CYCLOSPORIN; METHOTREXATE; TACROLIMUS;

ACUTE GRAFT VERSUS HOST DISEASE; ACUTE GRANULOCYTIC LEUKEMIA; ACUTE LYMPHOBLASTIC LEUKEMIA; ADOLESCENT; ALLOGENEIC PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; ALLOGRAFT; ARTICLE; BLOOD DONOR; BONE MARROW TRANSPLANTATION; CANCER PATIENT; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; CHILDHOOD LEUKEMIA; CHRONIC GRAFT VERSUS HOST DISEASE; CONTROLLED STUDY; DISEASE FREE SURVIVAL; FEMALE; GRAFT FAILURE; GRAFT SURVIVAL; GRAFT VERSUS HOST REACTION; HLA MATCHING; HOSPITALIZED CHILD; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; INCIDENCE; INFANT; INTERMETHOD COMPARISON; JAPANESE; MAJOR CLINICAL STUDY; MALE; NEUTROPHIL COUNT; NEWBORN; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; SCHOOL CHILD; SIBLING; THROMBOCYTE COUNT; TRANSPLANTATION TOLERANCE;

ACUTE LEUKAEMIA; BONE MARROW TRANSPLANTATION; CHILDREN; CHRONIC GRAFT-VERSUS-HOST DISEASE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION;

ADOLESCENT; ASIAN CONTINENTAL ANCESTRY GROUP; BONE MARROW TRANSPLANTATION; CHILD; CHILD, PRESCHOOL; CHRONIC DISEASE; DISEASE-FREE SURVIVAL; FEMALE; FOLLOW-UP STUDIES; GRAFT VS HOST DISEASE; HISTOCOMPATIBILITY TESTING; HUMANS; INFANT; INFANT, NEWBORN; JAPAN; LEUKEMIA, MYELOID, ACUTE; LIVING DONORS; MALE; PERIPHERAL BLOOD STEM CELL TRANSPLANTATION; PRECURSOR CELL LYMPHOBLASTIC LEUKEMIA-LYMPHOMA; RISK FACTORS; SIBLINGS; SURVIVAL RATE; TRANSPLANTATION, HOMOLOGOUS;

EID: 84880369012     PISSN: 15455009     EISSN: 15455017     Source Type: Journal    
DOI: 10.1002/pbc.24524     Document Type: Article

References (29)

1. Kessinger A, Smith DM, Strandjord SE, et al. Allogeneic transplantation of blood-derived T cell-depleted hemopoietic stem cells after myeloablative treatment in a patient with acute lymphoblastic leukemia. Bone Marrow Transplant 1989; 4:643-646 [PubMed: 2573397].
2. Russel NH, Hunter AE, Rogers S, et al. Peripheral blood stem cells as an alternative to marrow for allogeneic transplantation (letter). Lancet 1993; 341:1482 [PubMed: 8099182].
3. Heldal D, Tjonnfjord G, Brinch L, et al. A randomised study of allogeneic transplantation with stem cells from blood or bone marrow. Bone Marrow Transplant 2000; 25:1129-1136 [PubMed: 10849524].
4. Schmitz N, Bacigalupo A, Hasenclever D, et al. Allogeneic bone marrow transplantation vs filgrastim-mobilised peripheral blood progenitor cell transplantation in patients with early leukaemia: First results of a randomised multicentre trial of the European Group for Blood and Marrow Transplantation. Bone Marrow Transplant 1998; 21:995-1003 [PubMed: 9632272].
5. Vigorito AC, Azevedo WM, Marques JFC, et al. A randomized prospective comparison of allogeneic bone marrow and peripheral blood progenitor cell transplantation in the treatment of haematological malignancies. Bone Marrow Transplant 1998; 22:1145-1151 [PubMed: 9894716].
6. Blaise D, Kuentz M, Fortanier C, et al. Randomized trial of bone marrow versus lenograstim-primed blood cell allogeneic transplantation in patients with early-stage leukemia: A report from the Societe Francaise de Greffe de Moelle. J Clin Oncol 2000; 18:537-546 [PubMed: 10653869].
7. Gratwohl A, Baldomero H, Horisberger B, et al. Current trends in hematopoietic stem cell transplantation in Europe. Blood 2002; 100:2374-2386 [PubMed: 12239145].
8. Atsuta Y, Suzuki R, Yoshimi A, et al. Unification of hematopoietic stem cell transplantation registries in Japan and establishment of the TRUMP System. Int J hematol 2007; 86:269-274 [PubMed: 17988995].
9. Schmitz N, Beksac M, Hasenclever D, et al. Transplantation of mobilized peripheral blood cells to HLA-identical siblings with standard-risk leukemia. Blood 2002; 100:761-767 [PubMed: 12130483].
10. Schmitz N, Eapen M, Horowitz MM, et al. Long-term outcome of patients given transplants of mobilized blood or bone marrow: A report from the International Bone Marrow Transplant Registry and the European Group for Blood and Marrow Transplantation. Blood 2006; 108:4288-4290 [PubMed: 16946302].
11. Champlin RE, Schmitz N, Horowitz MM, et al. Blood stem cells compared with bone marrow as a source of hematopoietic cells for allogeneic transplantation. IBMTR Histocompatibility and Stem Cell Sources Working Committee and the European Group for Blood and Marrow Transplantation (EBMT). Blood 2000; 95:3702-3709 [PubMed: 10845900].
12. Powles R, Mehta J, Kulkarni S, et al. Allogeneic blood and bone-marrow stem-cell transplantation in haematological malignant diseases: A randomized trial. Lancet 2000; 355:1231-1237 [PubMed: 10770306].
13. Bensinger WI, Martin PJ, Storer B, et al. Transplantation of bone marrow as compared with peripheral-blood cells from HLA-identical relatives in patients with hematologic cancers. N Engl J Med 2001; 344:175-181 [PubMed: 11172139].
14. Couban S, Simpson DR, Barnett MJ, et al. A randomized multicenter comparison of bone marrow and peripheral blood in recipients of matched sibling allogeneic transplants for myeloid malignancies. Blood 2002; 100:1525-1531 [PubMed: 12176866].
15. Ringden O, Labopin M, Bacigalupo A, et al. Transplantation of peripheral blood stem cells as compared with bone marrow from HLAidentical siblings in adult patients with acute myeloid leukemia and acute lymphoblastic leukemia. J Clin Oncol 2002; 20:4655-4664 [PubMed: 12488410].
16. Przepiorka D, Weisdorf D, Martin P, et al. 1994; Consensus conference on acute GVHD grading. Bone Marrow Transplant 1995:825-828 [PubMed: 7581076].
17. Shulman HM, Sullivan KM, Weiden PL, et al. Chronic graft-versus-host syndrome in man. A long-term clinicopathologic study of 20 Seattle patients. Am J Med 1980; 69:204-217 [PubMed: 6996481].
18. Kaplan EL, Meier P. Nonparametric estimation from imcomplete observations. J Am Stat 1958; 53:457-481.
19. Cox DR. Regression models and life tables (with discussion). J Royal Stat, Series B 1972; 34:187-220.
20. Lin YF, Lairson DR, Chan W, et al. Children with acute leukemia: A comparison of outcomes from allogeneic blood stem cell and bone marrow transplantation. Pediatr Blood Cancer 2011; 56:143-151 [PubMed: 21108446].
21. Eapen M, Horowitz MM, Klein JP, et al. Higher mortality after allogeneic peripheral-blood transplantation compared with bone marrow in children and adolescents: The Histocompatibility and Alternate Stem Cell Source Working Committee of the International Bone Marrow Transplant Registry. J Clil Oncol 2004; 22:4872-4880 [PubMed: 15520055].
22. Schrezenmeier H, Passweg JR, Marsh JC, et al. Worse outcome and more chronic GVHD with peripheral blood progenitor cells than bone marrow in HLA-matched sibling donor transplants for young patients with severe acquired aplastic anemia. Blood. 2007; 110:1397-1400 [PubMed: 17475907].
23. Garderet L, Labopin M, Gorin NC, et al. Patients with acute lymphoblastic leukaemia allografted with a matched unrelated donor may have a lower survival with a peripheral blood stem cell graft compared to bone marrow. Bone Marrow Transplant 2003; 31:23-29 [PubMed: 12621503].
24. Pan L, Delmonte JJ, Jalonen CK, Ferrara JL. Pretreatment of donor mice with granulocyte colony-stimulating factor polarizes donor T lymphocytes toward type-2 cytokine production and reduces severity of experimental graft-versus-host disease. Blood 1995; 86:4422-4429 [PubMed: 8541530].
25. Zeng D, Dejbakhsh JS, Strober S. Granulocyte colony-stimulating factor reduces the capacity of blood mononuclear cells to induce graft-versus-host disease: Impact on blood progenitor cell transplantation. Blood 1997; 90:453-463 [PubMed: 9207483].
26. Cutler C, Giri S, Jeyapalan S, et al. Acute and chronic graft-versus-host disease after allogeneic peripheral-blood stem-cell and bone marrow transplantation: A meta-analysis. J Clin Oncol 2001; 19:3685-3691 [PubMed: 11504750].
27. Tanimoto TE, Yamaguchi T, Tanaka Y, et al. Comparative analysis of clinical outcomes after allogeneic bone marrow transplantation versus peripheral blood stem cell transplantation from a related donor in Japanese patients. Br J Haematol 2004; 125:480-493 [PubMed: 15142119].
28. Mohty M, Kuentz M, Michallet M, et al. Chronic graft-versus-host disease after allogeneic blood stem cell transplantation: Long-term results of a randomized study. Blood 2002; 100:3128-3134 [PubMed: 12384409].
29. Stem Cell Trialists' Collaborative Group. Allogeneic peripheral blood stem-cell compared with bone marrow transplantation in the management of hematologic malignancies: An individual patient data meta-analysis of nine randomized trials. J Clin Oncol 2005; 23:5074-5087 [PubMed: 16051954].